AOD-9604 Dosage: A Beginner's Guide to Amounts and Timing

Built by medical professionals, gym rats, and experienced biohackers

AOD-9604 is a synthetic peptide fragment studied for its role in fat metabolism. Most community references place the starting dose between 250 and 500 mcg per day, given as a single daily subcutaneous injection. Treat every figure in this guide as a reference point, not a prescription.

What Exactly Is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone, covering roughly amino acids 176 to 191 at the C-terminal end of the molecule. Early studies suggested this specific region plays a role in fat breakdown without triggering the full growth-promoting effects of complete growth hormone.

The peptide was originally developed at Monash University in Australia and later studied as an oral obesity drug candidate. It did not receive regulatory approval as a medicine. Today it circulates as a research compound only, not a licensed therapeutic.

What Doses Do Community References Cite?

Most discussions in research peptide communities point to a daily range of 250 to 500 mcg. Many users describe 300 mcg as a common starting point.

A few things worth knowing about those numbers:

Beginners typically start near the lower end, around 250 mcg, to observe individual response before adjusting.
Doses above 500 mcg appear in some advanced community discussions but are less commonly cited in early-stage research.
These units are micrograms, not milligrams. That difference matters enormously when drawing up a reconstituted peptide.

Community dose ranges are informal references. They do not reflect clinical approval or personalized medical guidance.

How Is AOD-9604 Typically Used?

AOD-9604 in research discussions is almost always described as a subcutaneous injection, meaning into the fat layer just under the skin. Commonly mentioned sites include the abdomen and upper thigh.

The peptide is sold as a lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before use. Microgram-level dosing leaves little room for measuring errors. A small mistake when reconstituting or drawing up a syringe can mean a meaningfully different amount than intended. Keeping a reconstitution log alongside a dose tracker is a habit many experienced users recommend.

What Timing Do People Follow?

Timing comes up frequently because of AOD-9604's fat-metabolism context. The most commonly described approach is a single morning injection on an empty stomach, sometimes timed before fasted cardio. Users cite the idea that fat-mobilizing processes may be less disrupted by food, though direct evidence comparing timing windows in controlled conditions is limited.

This is a common convention, not a proven requirement.

How Long Do People Run a Cycle?

Cycle length is almost always discussed alongside dose. Many community sources describe running AOD-9604 for 8 to 16 weeks, then pausing before resuming. The general reasoning is that long-term continuous use of any research peptide lacks robust human safety data, so breaks are treated as a precautionary norm.

No controlled trial has established an optimal cycle length for general use.

What About Combining It With Other Peptides?

Some experienced users discuss stacking AOD-9604 with peptides like CJC-1295 or Ipamorelin. These combinations have not been studied in combination trials, which means the unknowns multiply. Community guidance for beginners is to run a single compound first and become comfortable with its effects before adding anything else.

Is AOD-9604 Safe?

Human safety data is limited. Clinical trials conducted during its development as an oral obesity drug reported a generally tolerable profile at the doses and routes studied. That context differs from subcutaneous use as a research compound, where no equivalent controlled dataset exists.

Side effects mentioned in community reports include mild injection site reactions, headache, and fatigue. AOD-9604 cannot treat, cure, or prevent any condition. Anyone with an existing health condition, or who is pregnant or breastfeeding, should speak with a licensed clinician before considering any research peptide.

Why Getting the Math Right Matters

A 2 mg vial yields roughly 6 full doses at 300 mcg per day (2,000 mcg divided by 300 mcg). At 250 mcg per day, the same vial stretches to 8 doses. Small differences in the reconstitution volume or the amount drawn can shift those numbers quickly.

Tools like DoseVault at https://dosevault.app include a built-in reconstitution calculator and a daily dose log designed specifically for peptide tracking, so the math is handled and every dose is on record.

Quick FAQ

Do I have to fast before injecting?
Many users choose a fasted morning window, but controlled evidence on timing differences is limited. It is convention, not a proven rule.

Can AOD-9604 be taken orally?
The original pharmaceutical development used an oral form, but that differs from the injectable research compound now in circulation. Most community discussion focuses on subcutaneous injection.

Should I start at 250 or 300 mcg?
Community guidance consistently points to the lower end of any range when starting something new. This is common-sense convention, not a clinical protocol.

Is AOD-9604 the same as HGH?
No. It is a short fragment of the growth hormone molecule and does not carry the full range of effects associated with complete growth hormone use.

What is the difference between mcg and mg?
One milligram equals 1,000 micrograms. AOD-9604 doses are in micrograms. Confusing the two units is a significant error when measuring.

AOD-9604 dosage is measured in micrograms, most commonly cited between 250 and 300 mcg per day for beginners, timed to a fasted morning window. Track every dose carefully and treat all community numbers as informal references. For a reconstitution calculator and daily peptide log, visit https://dosevault.app.

This article is for general education only. It does not diagnose, treat, cure, or prevent any condition. Speak with a licensed healthcare professional before using any peptide or research compound.